Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 8:59 AM UTC
| NCT Number | NCT04893109 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | PHASE2 |
| Target Enrollment | 500 participants |
| Active Locations | 53 sites in the US |
| Sponsor | Dana-Farber Cancer Institute |
| Last Updated on CT.gov | August 19, 2026 (1 week ago) |
As of August 31, 2026: Clinical trial NCT04893109 is currently recruiting participants. This phase2 study for breast cancer is actively seeking new participants at 53 locations across the United States. The study is sponsored by Dana-Farber Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04893109 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 53 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04893109 was last updated 1 week ago (August 19, 2026). HelloStudys verifies this status automatically.